Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Session Type:

CME Eligible Sessions:

Availability:

  • Sort by:
  • Browse by:
<< first | < prev page: of 7 records per page: next > | last >>
pages: 1 2 3 4 5 6 7 presentations: 1 to 50 of 302
Welcome and Session Overview for the Scott M. Hammer Workshop for New Researchers and Trainees   (ABSTRACT 1)
from CROI 2026 on February 22, 2026 8:30 AM-12:30 PM
What Has the Advent of Capsid Inhibitors Taught Us About HIV Pathogenesis: Navigating Virology Presentations at CROI 2026
Stuart J. D. Neil
King's College London, London, UK
from CROI 2026 on February 22, 2026 8:30 AM-12:30 PM
Immunology of HIV Cure and Beyond: Navigating Immunology Presentations at CROI 2026
John Frater
University of Oxford, Oxford, UK
from CROI 2026 on February 22, 2026 8:30 AM-12:30 PM
Long-Acting HIV Treatment Regimens: Where Are We and Where Are We Going? Navigating HIV Treatment Presentations at CROI 2026
Ruanne V. Barnabas
Massachusetts General Hospital, Boston, MA, USA
from CROI 2026 on February 22, 2026 8:30 AM-12:30 PM
Taking Prevention to the Population Level: Navigating Implementation Science Presentations at CROI 2026
from CROI 2026 on February 22, 2026 8:30 AM-12:30 PM
Reclaiming the Narrative: Navigating Research Through Turbulent Times
Sunil S. Solomon
The Johns Hopkins University School of Medicine, Baltimore, MD, USA
from CROI 2026 on February 22, 2026 8:30 AM-12:30 PM
Questions and Answers
from CROI 2026 on February 22, 2026 8:30 AM-12:30 PM
Clinical Trials in the Post-Lenacapavir Era   (ABSTRACT 7)
David V. Glidden
University of California San Francisco, San Francisco, CA, USA
from CROI 2026 on February 22, 2026 2:00 PM-4:00 PM
Measurement of Outcomes in Health Care Delivery: Implementation Trials   (ABSTRACT 8)
Thomas A. Odeny
Washington University, St Louis, MO, USA
from CROI 2026 on February 22, 2026 2:00 PM-4:00 PM
Accounting for User Choice: Preference Trials in HIV Prevention and Treatment Research   (ABSTRACT 9)
Elizabeth R. Brown
Fred Hutchinson Cancer Center, Seattle, WA, USA
from CROI 2026 on February 22, 2026 2:00 PM-4:00 PM
Case Presentation With Panel Discussion, Plus Questions and Answers From the Audience   (ABSTRACT 6)
Sanjay Bhagani
Royal Free London NHS Foundation Trust, London, UK
Brenda E. Crabtree-Ramírez
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
Andrew D. Kambugu
Infectious Disease Institute, Kampala, Uganda
Susanna Naggie
Durham VA Health Care System, Durham, NC, USA
from CROI 2026 on February 22, 2026 2:00 PM-4:00 PM
Spatial Transcriptomic and Proteomic Profiling of HIV in Tissues   (ABSTRACT 2)
Zaza Ndhlovu
Africa Health Research Institute, Mtubatuba, South Africa
from CROI 2026 on February 22, 2026 2:00 PM-4:00 PM
Integrative Structural and Computational Approaches to RNA Biology   (ABSTRACT 3)
Megan Ken
The Scripps Research Institute, La Jolla, CA, USA
from CROI 2026 on February 22, 2026 2:00 PM-4:00 PM
Latent HIV Reversal via Functional Genomics and Single-Cell Perturbation Modeling   (ABSTRACT 4)
Wei Li
University of Maryland, Baltimore, MD, USA
from CROI 2026 on February 22, 2026 2:00 PM-4:00 PM
Welcome From the Conference Chair
Nicolas Chomont
Université de Montréal, Montreal, Canada
from CROI 2026 on February 22, 2026 5:00 PM-7:00 PM
Introduction to the Lifetime Achievement Award
Constance A. Benson
University of California San Diego, La Jolla, CA, USA
from CROI 2026 on February 22, 2026 5:00 PM-7:00 PM
Acceptance of the Lifetime Achievement Award
Carl W. Dieffenbach
Fogarty International Center, National Institutes of Health, Bethesda, MD, USA
from CROI 2026 on February 22, 2026 5:00 PM-7:00 PM
Introduction to the Bernard Fields Lecture
Nicolas Chomont
Université de Montréal, Montreal, Canada
from CROI 2026 on February 22, 2026 5:00 PM-7:00 PM
Unfinished Business: Thirty Years of Persistence, Progress, and Partnerships in HIV Cure Science   (ABSTRACT 10)
Sharon R. Lewin
The University of Melbourne, Melbourne, Australia
from CROI 2026 on February 22, 2026 5:00 PM-7:00 PM
Introduction to the Martin Delaney Presentation
Michael Louella
UW/Fred Hutch Center for AIDS Research (CFAR), Seattle, WA, USA
from CROI 2026 on February 22, 2026 5:00 PM-7:00 PM
''Annus Horribilis" and The War on Science: Thoughts on Resisting and Rebuilding   (ABSTRACT 11)
Peter Staley
PrEP4All, New York, NY, USA
from CROI 2026 on February 22, 2026 5:00 PM-7:00 PM
Introduction to the N'Galy-Mann Lecture
Wafaa M. El-Sadr
Columbia University, New York, NY, USA
from CROI 2026 on February 22, 2026 5:00 PM-7:00 PM
The ART of Prevention: People, Science, Progress   (ABSTRACT 12)
Linda-Gail Bekker
Desmond Tutu HIV Foundation, Cape Town, South Africa
from CROI 2026 on February 22, 2026 5:00 PM-7:00 PM
Conclusion of the Opening Session and Welcome to the Opening Reception
Peter W. Hunt
University of California San Francisco, San Francisco, CA, USA
from CROI 2026 on February 22, 2026 5:00 PM-7:00 PM
CROI Program Committee Chair Welcome to Monday
Peter W. Hunt
University of California San Francisco, San Francisco, CA, USA
from CROI 2026 on February 23, 2026 8:30 AM-9:30 AM
Meeting the Moment: HIV Treatment and Prevention   (ABSTRACT 13)
Ilesh Jani
Mozambique National Institute of Health, Maputo, Mozambique
from CROI 2026 on February 23, 2026 8:30 AM-9:30 AM
Structure, Function, and Inhibition of the HIV Capsid   (ABSTRACT 14)
Wesley I. Sundquist
University of Utah, Salt Lake City, UT, USA
from CROI 2026 on February 23, 2026 8:30 AM-9:30 AM
Increased Risk of Heart Failure With Preserved Ejection Fraction in South Africans With HIV   (ABSTRACT 116)
Zaayid Omar
University of Cape Town, Cape Town, South Africa
from CROI 2026 on February 23, 2026 10:00 AM-12:00 PM
Relationship of Inflammatory, Cardiac, and Lipid Biomarkers to Cardiovascular Events in REPRIEVE   (ABSTRACT 117)
Steven Grinspoon
Massachusetts General Hospital, Boston, MA, USA
from CROI 2026 on February 23, 2026 10:00 AM-12:00 PM
Incident Hypertension in REPRIEVE: Risk Factors, Pitavastatin Effect & Cardiovascular Consequences   (ABSTRACT 118)
Esteban Martinez
Hospital Clinic of Barcelona, Barcelona, Spain
from CROI 2026 on February 23, 2026 10:00 AM-12:00 PM
Population-Level Obesity Trends by HIV Status in Pre-/Post-DTG Era in Rural East Africa SEARCH Study   (ABSTRACT 119)
Elijah R. Kakande
Infectious Disease Research Collaboration, Kampala, Uganda
from CROI 2026 on February 23, 2026 10:00 AM-12:00 PM
Questions and Answers (Part 1)
from CROI 2026 on February 23, 2026 10:00 AM-12:00 PM
Weight Rebound After Discontinuing Metformin in PWH Without Diabetes: Week 144 Trial Results   (ABSTRACT 120)
Cristina Marcelo Calvo
La Paz University Hospital, Madrid, Spain
from CROI 2026 on February 23, 2026 10:00 AM-12:00 PM
Rates and Risk Factors for Oropharyngeal Squamous Cell Carcinoma Among People Living With HIV   (ABSTRACT 121)
Antonio Bandala-Jacques
The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
from CROI 2026 on February 23, 2026 10:00 AM-12:00 PM
Kaposi Sarcoma Herpesvirus in Plasma: Association With Treatment Failure in Limited-Stage AIDS-KS   (ABSTRACT 122)
Dirk P. Dittmer
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
from CROI 2026 on February 23, 2026 10:00 AM-12:00 PM
Intensification of Tuberculosis Treatment in Severely Immunocompromised Individuals With HIV   (ABSTRACT 123)
François-Xavier Blanc
University Hospital of Nantes, Nantes, France
from CROI 2026 on February 23, 2026 10:00 AM-12:00 PM
Adjunctive Prednisone for Inpatients With Disseminated HIV-Associated TB   (ABSTRACT 124)
Phiona E. Namale
University of Cape Town, Cape Town, South Africa
from CROI 2026 on February 23, 2026 10:00 AM-12:00 PM
Questions and Answers (Part 2)
from CROI 2026 on February 23, 2026 10:00 AM-12:00 PM
Introduction of Speakers (Part 1)
from CROI 2026 on February 23, 2026 10:00 AM-12:00 PM
Implants Releasing NRTTI MK-8591 Fail to Protect Macaques Against SHIV Containing the M184V Mutation   (ABSTRACT 125)
Charles Dobard
Centers for Disease Control and Prevention, Atlanta, GA, USA
from CROI 2026 on February 23, 2026 10:00 AM-12:00 PM
MK-8527 Phase III Dose Selection for Monthly Oral HIV-1 Preexposure Prophylaxis   (ABSTRACT 126)
Yash Kapoor
Merck Sharp & Dohme, Rahway, NJ, USA
from CROI 2026 on February 23, 2026 10:00 AM-12:00 PM
Final Results of the ANRS PREVENIR Study With Daily or On-Demand Oral PrEP With TDF/FTC in Paris   (ABSTRACT 127)
Jean-Michel Molina
Assistance Publique – Hôpitaux de Paris, Paris, France
from CROI 2026 on February 23, 2026 10:00 AM-12:00 PM
Twice-Yearly Subcutaneous Lenacapavir for PrEP: Updated HIV-1 Incidence and Safety Data in PURPOSE 1   (ABSTRACT 128)
Nkosiphile Ndlovu
Wits Reproductive Health and HIV Institute, Johannesburg, South Africa
from CROI 2026 on February 23, 2026 10:00 AM-12:00 PM
Questions and Answers (Part 1)
from CROI 2026 on February 23, 2026 10:00 AM-12:00 PM
Lenacapavir for PrEP: HIV-1 Incidence and Safety From PURPOSE 2 at End of Randomized Blinded Phase   (ABSTRACT 129)
Valeria D. Cantos Lucio
Emory University, Atlanta, GA, USA
from CROI 2026 on February 23, 2026 10:00 AM-12:00 PM
Resistance Analyses of the PURPOSE Studies Through the End of the Randomized Blinded Phase   (ABSTRACT 130)
Stephanie Cox
Gilead Sciences, Inc, Foster City, CA, USA
from CROI 2026 on February 23, 2026 10:00 AM-12:00 PM
RCT of Dynamic Choice to Provide Oral PrEP to Postpartum South African Women   (ABSTRACT 131)
Dvora L. Joseph Davey
University of California Los Angeles, Los Angeles, CA, USA
from CROI 2026 on February 23, 2026 10:00 AM-12:00 PM
Effect of Different Pharmacy PrEP Delivery Models on Initiation and Continuation in Kenya: A cRCT   (ABSTRACT 132)
Katrina F. Ortblad
Fred Hutchinson Cancer Center, Seattle, WA, USA
from CROI 2026 on February 23, 2026 10:00 AM-12:00 PM
Questions and Answers (Part 2)
from CROI 2026 on February 23, 2026 10:00 AM-12:00 PM
Impact of Elevated S100A8/A9 and Classical Monocytes on Cerebrovascular Dysfunction in Long COVID   (ABSTRACT 108)
Meera V. Singh
University of Rochester Medical Center, Rochester, NY, USA
from CROI 2026 on February 23, 2026 10:00 AM-12:00 PM
<< first | < prev page: of 7 records per page: next > | last >>
pages: 1 2 3 4 5 6 7 presentations: 1 to 50 of 302